Article
The presence of monoclonal gammopathy in Ph-negative myeloproliferative neoplasms is associated with a detrimental effect on outcomes.
Leukemia & lymphoma - 1 Nov 2017
Le Clech Lenaïg, Sakka Mehdi, Meskar Ahmed, Kerspern Helene, Eveillard Jean-Richard, Berthou Christian, Buors Caroline, Lippert Eric, Guillerm Gaelle, Quintin-Roué Isabelle, Carré Jean-Luc, Ianotto Jean-Christophe
Abstract excerpt
Many case reports have indicated the occurrence of monoclonal gammopathy of uncertain significance (MGUS) or multiple myeloma (MM) in patients with Ph-negative myeloproliferative neoplasms (MPN), but few cohorts of patients have been published. This study concerns 667 patients newly diagnosed with polycythemia vera (PV) or essential thrombocythemia (ET) who were tested for monoclonal (M) protein at diagnosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
